Medical Care
Global Alzheimer's Disease Blood Diagnostic Market Research Report 2025
- Jan 16, 26
- ID: 675100
- Pages: 88
- Figures: 87
- Views: 6
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Blood Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Blood Diagnostic.
The Alzheimer's Disease Blood Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alzheimer's Disease Blood Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease Blood Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quanterix
C2N Diagnostics
Sysmex
Quest Diagnostics
Roche Diagnostics
Eli Lilly and Company
Fujirebio
Amoneta Diagnostics
MagQu
Vazyme
KingMed Diagnostics
Anqun Bioengineering
Segment by Type
Amyloid Beta (Aβ)
Tau Proteins
Others
Segment by Application
Early Diagnosis
Clinical Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Disease Blood Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Alzheimer's Disease Blood Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alzheimer's Disease Blood Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease Blood Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quanterix
C2N Diagnostics
Sysmex
Quest Diagnostics
Roche Diagnostics
Eli Lilly and Company
Fujirebio
Amoneta Diagnostics
MagQu
Vazyme
KingMed Diagnostics
Anqun Bioengineering
Segment by Type
Amyloid Beta (Aβ)
Tau Proteins
Others
Segment by Application
Early Diagnosis
Clinical Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Disease Blood Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Amyloid Beta (Aβ)
1.2.3 Tau Proteins
1.2.4 Others
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Blood Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Early Diagnosis
1.3.3 Clinical Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer's Disease Blood Diagnostic Market Perspective (2020-2031)
2.2 Global Alzheimer's Disease Blood Diagnostic Growth Trends by Region
2.2.1 Global Alzheimer's Disease Blood Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Alzheimer's Disease Blood Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Alzheimer's Disease Blood Diagnostic Market Dynamics
2.3.1 Alzheimer's Disease Blood Diagnostic Industry Trends
2.3.2 Alzheimer's Disease Blood Diagnostic Market Drivers
2.3.3 Alzheimer's Disease Blood Diagnostic Market Challenges
2.3.4 Alzheimer's Disease Blood Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer's Disease Blood Diagnostic Players by Revenue
3.1.1 Global Top Alzheimer's Disease Blood Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Alzheimer's Disease Blood Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Alzheimer's Disease Blood Diagnostic Revenue
3.4 Global Alzheimer's Disease Blood Diagnostic Market Concentration Ratio
3.4.1 Global Alzheimer's Disease Blood Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Blood Diagnostic Revenue in 2024
3.5 Global Key Players of Alzheimer's Disease Blood Diagnostic Head office and Area Served
3.6 Global Key Players of Alzheimer's Disease Blood Diagnostic, Product and Application
3.7 Global Key Players of Alzheimer's Disease Blood Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer's Disease Blood Diagnostic Breakdown Data by Type
4.1 Global Alzheimer's Disease Blood Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Type (2026-2031)
5 Alzheimer's Disease Blood Diagnostic Breakdown Data by Application
5.1 Global Alzheimer's Disease Blood Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Alzheimer's Disease Blood Diagnostic Market Size (2020-2031)
6.2 North America Alzheimer's Disease Blood Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025)
6.4 North America Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer's Disease Blood Diagnostic Market Size (2020-2031)
7.2 Europe Alzheimer's Disease Blood Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025)
7.4 Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer's Disease Blood Diagnostic Market Size (2020-2031)
9.2 Latin America Alzheimer's Disease Blood Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quanterix
11.1.1 Quanterix Company Details
11.1.2 Quanterix Business Overview
11.1.3 Quanterix Alzheimer's Disease Blood Diagnostic Introduction
11.1.4 Quanterix Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.1.5 Quanterix Recent Development
11.2 C2N Diagnostics
11.2.1 C2N Diagnostics Company Details
11.2.2 C2N Diagnostics Business Overview
11.2.3 C2N Diagnostics Alzheimer's Disease Blood Diagnostic Introduction
11.2.4 C2N Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.2.5 C2N Diagnostics Recent Development
11.3 Sysmex
11.3.1 Sysmex Company Details
11.3.2 Sysmex Business Overview
11.3.3 Sysmex Alzheimer's Disease Blood Diagnostic Introduction
11.3.4 Sysmex Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.3.5 Sysmex Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Details
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Alzheimer's Disease Blood Diagnostic Introduction
11.4.4 Quest Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.4.5 Quest Diagnostics Recent Development
11.5 Roche Diagnostics
11.5.1 Roche Diagnostics Company Details
11.5.2 Roche Diagnostics Business Overview
11.5.3 Roche Diagnostics Alzheimer's Disease Blood Diagnostic Introduction
11.5.4 Roche Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.5.5 Roche Diagnostics Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Introduction
11.6.4 Eli Lilly and Company Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.6.5 Eli Lilly and Company Recent Development
11.7 Fujirebio
11.7.1 Fujirebio Company Details
11.7.2 Fujirebio Business Overview
11.7.3 Fujirebio Alzheimer's Disease Blood Diagnostic Introduction
11.7.4 Fujirebio Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.7.5 Fujirebio Recent Development
11.8 Amoneta Diagnostics
11.8.1 Amoneta Diagnostics Company Details
11.8.2 Amoneta Diagnostics Business Overview
11.8.3 Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Introduction
11.8.4 Amoneta Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.8.5 Amoneta Diagnostics Recent Development
11.9 MagQu
11.9.1 MagQu Company Details
11.9.2 MagQu Business Overview
11.9.3 MagQu Alzheimer's Disease Blood Diagnostic Introduction
11.9.4 MagQu Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.9.5 MagQu Recent Development
11.10 Vazyme
11.10.1 Vazyme Company Details
11.10.2 Vazyme Business Overview
11.10.3 Vazyme Alzheimer's Disease Blood Diagnostic Introduction
11.10.4 Vazyme Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.10.5 Vazyme Recent Development
11.11 KingMed Diagnostics
11.11.1 KingMed Diagnostics Company Details
11.11.2 KingMed Diagnostics Business Overview
11.11.3 KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Introduction
11.11.4 KingMed Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.11.5 KingMed Diagnostics Recent Development
11.12 Anqun Bioengineering
11.12.1 Anqun Bioengineering Company Details
11.12.2 Anqun Bioengineering Business Overview
11.12.3 Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Introduction
11.12.4 Anqun Bioengineering Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.12.5 Anqun Bioengineering Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Amyloid Beta (Aβ)
1.2.3 Tau Proteins
1.2.4 Others
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Blood Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Early Diagnosis
1.3.3 Clinical Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer's Disease Blood Diagnostic Market Perspective (2020-2031)
2.2 Global Alzheimer's Disease Blood Diagnostic Growth Trends by Region
2.2.1 Global Alzheimer's Disease Blood Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Alzheimer's Disease Blood Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Alzheimer's Disease Blood Diagnostic Market Dynamics
2.3.1 Alzheimer's Disease Blood Diagnostic Industry Trends
2.3.2 Alzheimer's Disease Blood Diagnostic Market Drivers
2.3.3 Alzheimer's Disease Blood Diagnostic Market Challenges
2.3.4 Alzheimer's Disease Blood Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer's Disease Blood Diagnostic Players by Revenue
3.1.1 Global Top Alzheimer's Disease Blood Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Alzheimer's Disease Blood Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Alzheimer's Disease Blood Diagnostic Revenue
3.4 Global Alzheimer's Disease Blood Diagnostic Market Concentration Ratio
3.4.1 Global Alzheimer's Disease Blood Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Blood Diagnostic Revenue in 2024
3.5 Global Key Players of Alzheimer's Disease Blood Diagnostic Head office and Area Served
3.6 Global Key Players of Alzheimer's Disease Blood Diagnostic, Product and Application
3.7 Global Key Players of Alzheimer's Disease Blood Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer's Disease Blood Diagnostic Breakdown Data by Type
4.1 Global Alzheimer's Disease Blood Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Type (2026-2031)
5 Alzheimer's Disease Blood Diagnostic Breakdown Data by Application
5.1 Global Alzheimer's Disease Blood Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Alzheimer's Disease Blood Diagnostic Market Size (2020-2031)
6.2 North America Alzheimer's Disease Blood Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025)
6.4 North America Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer's Disease Blood Diagnostic Market Size (2020-2031)
7.2 Europe Alzheimer's Disease Blood Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025)
7.4 Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer's Disease Blood Diagnostic Market Size (2020-2031)
9.2 Latin America Alzheimer's Disease Blood Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quanterix
11.1.1 Quanterix Company Details
11.1.2 Quanterix Business Overview
11.1.3 Quanterix Alzheimer's Disease Blood Diagnostic Introduction
11.1.4 Quanterix Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.1.5 Quanterix Recent Development
11.2 C2N Diagnostics
11.2.1 C2N Diagnostics Company Details
11.2.2 C2N Diagnostics Business Overview
11.2.3 C2N Diagnostics Alzheimer's Disease Blood Diagnostic Introduction
11.2.4 C2N Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.2.5 C2N Diagnostics Recent Development
11.3 Sysmex
11.3.1 Sysmex Company Details
11.3.2 Sysmex Business Overview
11.3.3 Sysmex Alzheimer's Disease Blood Diagnostic Introduction
11.3.4 Sysmex Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.3.5 Sysmex Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Details
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Alzheimer's Disease Blood Diagnostic Introduction
11.4.4 Quest Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.4.5 Quest Diagnostics Recent Development
11.5 Roche Diagnostics
11.5.1 Roche Diagnostics Company Details
11.5.2 Roche Diagnostics Business Overview
11.5.3 Roche Diagnostics Alzheimer's Disease Blood Diagnostic Introduction
11.5.4 Roche Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.5.5 Roche Diagnostics Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Introduction
11.6.4 Eli Lilly and Company Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.6.5 Eli Lilly and Company Recent Development
11.7 Fujirebio
11.7.1 Fujirebio Company Details
11.7.2 Fujirebio Business Overview
11.7.3 Fujirebio Alzheimer's Disease Blood Diagnostic Introduction
11.7.4 Fujirebio Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.7.5 Fujirebio Recent Development
11.8 Amoneta Diagnostics
11.8.1 Amoneta Diagnostics Company Details
11.8.2 Amoneta Diagnostics Business Overview
11.8.3 Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Introduction
11.8.4 Amoneta Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.8.5 Amoneta Diagnostics Recent Development
11.9 MagQu
11.9.1 MagQu Company Details
11.9.2 MagQu Business Overview
11.9.3 MagQu Alzheimer's Disease Blood Diagnostic Introduction
11.9.4 MagQu Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.9.5 MagQu Recent Development
11.10 Vazyme
11.10.1 Vazyme Company Details
11.10.2 Vazyme Business Overview
11.10.3 Vazyme Alzheimer's Disease Blood Diagnostic Introduction
11.10.4 Vazyme Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.10.5 Vazyme Recent Development
11.11 KingMed Diagnostics
11.11.1 KingMed Diagnostics Company Details
11.11.2 KingMed Diagnostics Business Overview
11.11.3 KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Introduction
11.11.4 KingMed Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.11.5 KingMed Diagnostics Recent Development
11.12 Anqun Bioengineering
11.12.1 Anqun Bioengineering Company Details
11.12.2 Anqun Bioengineering Business Overview
11.12.3 Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Introduction
11.12.4 Anqun Bioengineering Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
11.12.5 Anqun Bioengineering Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Amyloid Beta (Aβ)
Table 3. Key Players of Tau Proteins
Table 4. Key Players of Others
Table 5. Global Alzheimer's Disease Blood Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Alzheimer's Disease Blood Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Alzheimer's Disease Blood Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Alzheimer's Disease Blood Diagnostic Market Share by Region (2020-2025)
Table 9. Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Alzheimer's Disease Blood Diagnostic Market Share by Region (2026-2031)
Table 11. Alzheimer's Disease Blood Diagnostic Market Trends
Table 12. Alzheimer's Disease Blood Diagnostic Market Drivers
Table 13. Alzheimer's Disease Blood Diagnostic Market Challenges
Table 14. Alzheimer's Disease Blood Diagnostic Market Restraints
Table 15. Global Alzheimer's Disease Blood Diagnostic Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Alzheimer's Disease Blood Diagnostic Market Share by Players (2020-2025)
Table 17. Global Top Alzheimer's Disease Blood Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Blood Diagnostic as of 2024)
Table 18. Ranking of Global Top Alzheimer's Disease Blood Diagnostic Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Alzheimer's Disease Blood Diagnostic Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Alzheimer's Disease Blood Diagnostic, Headquarters and Area Served
Table 21. Global Key Players of Alzheimer's Disease Blood Diagnostic, Product and Application
Table 22. Global Key Players of Alzheimer's Disease Blood Diagnostic, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Alzheimer's Disease Blood Diagnostic Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Type (2020-2025)
Table 26. Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Type (2026-2031)
Table 28. Global Alzheimer's Disease Blood Diagnostic Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Application (2020-2025)
Table 30. Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Application (2026-2031)
Table 32. North America Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 47. Quanterix Company Details
Table 48. Quanterix Business Overview
Table 49. Quanterix Alzheimer's Disease Blood Diagnostic Product
Table 50. Quanterix Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 51. Quanterix Recent Development
Table 52. C2N Diagnostics Company Details
Table 53. C2N Diagnostics Business Overview
Table 54. C2N Diagnostics Alzheimer's Disease Blood Diagnostic Product
Table 55. C2N Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 56. C2N Diagnostics Recent Development
Table 57. Sysmex Company Details
Table 58. Sysmex Business Overview
Table 59. Sysmex Alzheimer's Disease Blood Diagnostic Product
Table 60. Sysmex Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 61. Sysmex Recent Development
Table 62. Quest Diagnostics Company Details
Table 63. Quest Diagnostics Business Overview
Table 64. Quest Diagnostics Alzheimer's Disease Blood Diagnostic Product
Table 65. Quest Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 66. Quest Diagnostics Recent Development
Table 67. Roche Diagnostics Company Details
Table 68. Roche Diagnostics Business Overview
Table 69. Roche Diagnostics Alzheimer's Disease Blood Diagnostic Product
Table 70. Roche Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 71. Roche Diagnostics Recent Development
Table 72. Eli Lilly and Company Company Details
Table 73. Eli Lilly and Company Business Overview
Table 74. Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Product
Table 75. Eli Lilly and Company Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 76. Eli Lilly and Company Recent Development
Table 77. Fujirebio Company Details
Table 78. Fujirebio Business Overview
Table 79. Fujirebio Alzheimer's Disease Blood Diagnostic Product
Table 80. Fujirebio Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 81. Fujirebio Recent Development
Table 82. Amoneta Diagnostics Company Details
Table 83. Amoneta Diagnostics Business Overview
Table 84. Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Product
Table 85. Amoneta Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 86. Amoneta Diagnostics Recent Development
Table 87. MagQu Company Details
Table 88. MagQu Business Overview
Table 89. MagQu Alzheimer's Disease Blood Diagnostic Product
Table 90. MagQu Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 91. MagQu Recent Development
Table 92. Vazyme Company Details
Table 93. Vazyme Business Overview
Table 94. Vazyme Alzheimer's Disease Blood Diagnostic Product
Table 95. Vazyme Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 96. Vazyme Recent Development
Table 97. KingMed Diagnostics Company Details
Table 98. KingMed Diagnostics Business Overview
Table 99. KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Product
Table 100. KingMed Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 101. KingMed Diagnostics Recent Development
Table 102. Anqun Bioengineering Company Details
Table 103. Anqun Bioengineering Business Overview
Table 104. Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Product
Table 105. Anqun Bioengineering Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 106. Anqun Bioengineering Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Alzheimer's Disease Blood Diagnostic Picture
Figure 2. Global Alzheimer's Disease Blood Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alzheimer's Disease Blood Diagnostic Market Share by Type: 2024 VS 2031
Figure 4. Amyloid Beta (Aβ) Features
Figure 5. Tau Proteins Features
Figure 6. Others Features
Figure 7. Global Alzheimer's Disease Blood Diagnostic Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Alzheimer's Disease Blood Diagnostic Market Share by Application: 2024 VS 2031
Figure 9. Early Diagnosis Case Studies
Figure 10. Clinical Research Case Studies
Figure 11. Alzheimer's Disease Blood Diagnostic Report Years Considered
Figure 12. Global Alzheimer's Disease Blood Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Alzheimer's Disease Blood Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Alzheimer's Disease Blood Diagnostic Market Share by Region: 2024 VS 2031
Figure 15. Global Alzheimer's Disease Blood Diagnostic Market Share by Players in 2024
Figure 16. Global Top Alzheimer's Disease Blood Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Blood Diagnostic as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Alzheimer's Disease Blood Diagnostic Revenue in 2024
Figure 18. North America Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Alzheimer's Disease Blood Diagnostic Market Share by Country (2020-2031)
Figure 20. United States Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Alzheimer's Disease Blood Diagnostic Market Share by Country (2020-2031)
Figure 24. Germany Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Share by Region (2020-2031)
Figure 32. China Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Alzheimer's Disease Blood Diagnostic Market Share by Country (2020-2031)
Figure 40. Mexico Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Share by Country (2020-2031)
Figure 44. Turkey Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Quanterix Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 48. C2N Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 49. Sysmex Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 50. Quest Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 51. Roche Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 53. Fujirebio Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 54. Amoneta Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 55. MagQu Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 56. Vazyme Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 57. KingMed Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 58. Anqun Bioengineering Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Amyloid Beta (Aβ)
Table 3. Key Players of Tau Proteins
Table 4. Key Players of Others
Table 5. Global Alzheimer's Disease Blood Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Alzheimer's Disease Blood Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Alzheimer's Disease Blood Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Alzheimer's Disease Blood Diagnostic Market Share by Region (2020-2025)
Table 9. Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Alzheimer's Disease Blood Diagnostic Market Share by Region (2026-2031)
Table 11. Alzheimer's Disease Blood Diagnostic Market Trends
Table 12. Alzheimer's Disease Blood Diagnostic Market Drivers
Table 13. Alzheimer's Disease Blood Diagnostic Market Challenges
Table 14. Alzheimer's Disease Blood Diagnostic Market Restraints
Table 15. Global Alzheimer's Disease Blood Diagnostic Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Alzheimer's Disease Blood Diagnostic Market Share by Players (2020-2025)
Table 17. Global Top Alzheimer's Disease Blood Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Blood Diagnostic as of 2024)
Table 18. Ranking of Global Top Alzheimer's Disease Blood Diagnostic Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Alzheimer's Disease Blood Diagnostic Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Alzheimer's Disease Blood Diagnostic, Headquarters and Area Served
Table 21. Global Key Players of Alzheimer's Disease Blood Diagnostic, Product and Application
Table 22. Global Key Players of Alzheimer's Disease Blood Diagnostic, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Alzheimer's Disease Blood Diagnostic Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Type (2020-2025)
Table 26. Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Type (2026-2031)
Table 28. Global Alzheimer's Disease Blood Diagnostic Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Application (2020-2025)
Table 30. Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Application (2026-2031)
Table 32. North America Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 47. Quanterix Company Details
Table 48. Quanterix Business Overview
Table 49. Quanterix Alzheimer's Disease Blood Diagnostic Product
Table 50. Quanterix Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 51. Quanterix Recent Development
Table 52. C2N Diagnostics Company Details
Table 53. C2N Diagnostics Business Overview
Table 54. C2N Diagnostics Alzheimer's Disease Blood Diagnostic Product
Table 55. C2N Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 56. C2N Diagnostics Recent Development
Table 57. Sysmex Company Details
Table 58. Sysmex Business Overview
Table 59. Sysmex Alzheimer's Disease Blood Diagnostic Product
Table 60. Sysmex Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 61. Sysmex Recent Development
Table 62. Quest Diagnostics Company Details
Table 63. Quest Diagnostics Business Overview
Table 64. Quest Diagnostics Alzheimer's Disease Blood Diagnostic Product
Table 65. Quest Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 66. Quest Diagnostics Recent Development
Table 67. Roche Diagnostics Company Details
Table 68. Roche Diagnostics Business Overview
Table 69. Roche Diagnostics Alzheimer's Disease Blood Diagnostic Product
Table 70. Roche Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 71. Roche Diagnostics Recent Development
Table 72. Eli Lilly and Company Company Details
Table 73. Eli Lilly and Company Business Overview
Table 74. Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Product
Table 75. Eli Lilly and Company Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 76. Eli Lilly and Company Recent Development
Table 77. Fujirebio Company Details
Table 78. Fujirebio Business Overview
Table 79. Fujirebio Alzheimer's Disease Blood Diagnostic Product
Table 80. Fujirebio Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 81. Fujirebio Recent Development
Table 82. Amoneta Diagnostics Company Details
Table 83. Amoneta Diagnostics Business Overview
Table 84. Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Product
Table 85. Amoneta Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 86. Amoneta Diagnostics Recent Development
Table 87. MagQu Company Details
Table 88. MagQu Business Overview
Table 89. MagQu Alzheimer's Disease Blood Diagnostic Product
Table 90. MagQu Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 91. MagQu Recent Development
Table 92. Vazyme Company Details
Table 93. Vazyme Business Overview
Table 94. Vazyme Alzheimer's Disease Blood Diagnostic Product
Table 95. Vazyme Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 96. Vazyme Recent Development
Table 97. KingMed Diagnostics Company Details
Table 98. KingMed Diagnostics Business Overview
Table 99. KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Product
Table 100. KingMed Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 101. KingMed Diagnostics Recent Development
Table 102. Anqun Bioengineering Company Details
Table 103. Anqun Bioengineering Business Overview
Table 104. Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Product
Table 105. Anqun Bioengineering Revenue in Alzheimer's Disease Blood Diagnostic Business (2020-2025) & (US$ Million)
Table 106. Anqun Bioengineering Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Alzheimer's Disease Blood Diagnostic Picture
Figure 2. Global Alzheimer's Disease Blood Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alzheimer's Disease Blood Diagnostic Market Share by Type: 2024 VS 2031
Figure 4. Amyloid Beta (Aβ) Features
Figure 5. Tau Proteins Features
Figure 6. Others Features
Figure 7. Global Alzheimer's Disease Blood Diagnostic Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Alzheimer's Disease Blood Diagnostic Market Share by Application: 2024 VS 2031
Figure 9. Early Diagnosis Case Studies
Figure 10. Clinical Research Case Studies
Figure 11. Alzheimer's Disease Blood Diagnostic Report Years Considered
Figure 12. Global Alzheimer's Disease Blood Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Alzheimer's Disease Blood Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Alzheimer's Disease Blood Diagnostic Market Share by Region: 2024 VS 2031
Figure 15. Global Alzheimer's Disease Blood Diagnostic Market Share by Players in 2024
Figure 16. Global Top Alzheimer's Disease Blood Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Blood Diagnostic as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Alzheimer's Disease Blood Diagnostic Revenue in 2024
Figure 18. North America Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Alzheimer's Disease Blood Diagnostic Market Share by Country (2020-2031)
Figure 20. United States Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Alzheimer's Disease Blood Diagnostic Market Share by Country (2020-2031)
Figure 24. Germany Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Share by Region (2020-2031)
Figure 32. China Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Alzheimer's Disease Blood Diagnostic Market Share by Country (2020-2031)
Figure 40. Mexico Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Share by Country (2020-2031)
Figure 44. Turkey Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Quanterix Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 48. C2N Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 49. Sysmex Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 50. Quest Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 51. Roche Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 53. Fujirebio Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 54. Amoneta Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 55. MagQu Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 56. Vazyme Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 57. KingMed Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 58. Anqun Bioengineering Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232